Sofinno­va Part­ners builds stacks [on stacks, on stacks] as fund breaks past $2B mark

Just in case you were con­cerned that Sofinno­va Part­ners might be get­ting dis­tract­ed by its new late-stage for­ays, the cor­ner­stone French life sci­ence VC an­nounced a new ear­ly-stage fund worth a third of a bil­lion eu­ros, or $370 mil­lion.

Sofinno­va Cap­i­tal IX will pro­vide found­ing and lead in­vest­ments to star­tups and cor­po­rate spin­offs in the biotech and med­ical de­vice in­dus­tries, where the bulk of the com­pa­ny’s vast reser­voirs have been pushed to date. The new fund brings the com­pa­ny to $1 bil­lion raised over the last 4 years – half of the $2 bil­lion it says it now man­ages.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER